CELLAPEUTICSBIO
Latest round
- Series A
Last raised
- May 2023
Total raised
- $3.7M
Investors
- 4
About CELLAPEUTICSBIO
Founded in 2020 and based in Seongnam-si, South Korea, CELLAPEUTICSBIO is a cell therapy reprogramming company specializing in cells and antibody combinations used in the development of a treatment for severe intractable nerve damage.
Who invested in CELLAPEUTICSBIO
4 investors across 2 rounds
See all investors in CELLAPEUTICSBIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CELLAPEUTICSBIO
Who invested in CELLAPEUTICSBIO?
CELLAPEUTICSBIO has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CELLAPEUTICSBIO raised?
CELLAPEUTICSBIO has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CELLAPEUTICSBIO last raise money?
CELLAPEUTICSBIO's most recent round on record is a Series A, in May 2023.
What does CELLAPEUTICSBIO do?
Founded in 2020 and based in Seongnam-si, South Korea, CELLAPEUTICSBIO is a cell therapy reprogramming company specializing in cells and antibody combinations used in the development of a treatment for severe intractable nerve damage.
Where is CELLAPEUTICSBIO headquartered?
CELLAPEUTICSBIO is headquartered in Seongnam, South Korea.
Which VCs invest in companies like CELLAPEUTICSBIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at CELLAPEUTICSBIO's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like CELLAPEUTICSBIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.